NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/14/2022
Back to search
Official data from USPTO
SKIN GENES RX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
06/14/2022
Trademark type
Combined
Nice classes
44
Filing date
06/07/2019
Registration date
06/14/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2022
Last transaction
06/14/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use, Foreign priority
First use anywhere
10/24/2020
First use in commerce
10/24/2020
Drawing code
3
Owner type
01
Owner location
Toronto, Ontario, CA
Examiner
DEAN, JULES
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "SKIN GENES" in gray followed by the prescription symbol represented by the stylized lettering "RX" in purple.
Holders and representatives
Holders
D. C. (pessoa física)
Representatives
Maria v. Hardison Tassan & Hardison
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical advice in the nature of recommending treatment options for skin conditions based on the results of testing in the field of genetics and skin phenotyping; consultation services relating to skin care in the nature of online medical and cosmetic skincare consultation services; Providing medical analysis in the nature of recommending treatment options for skin conditions based on the results of testing in the field of genetics and skin phenotyping; online consultation services relating to medical and cosmetic skin care
Publications
History of USPTO decisions and trademark events.
59 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/14/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/09/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/03/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/03/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/28/2022
IUAA
USE AMENDMENT ACCEPTED
04/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/30/2021
GNRT
NON-FINAL ACTION E-MAILED
09/30/2021
CNRT
NON-FINAL ACTION WRITTEN
09/30/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/20/2021
IUAF
USE AMENDMENT FILED
08/20/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2021
ALIE
ASSIGNED TO LIE
08/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2021
GNRT
NON-FINAL ACTION E-MAILED
03/06/2021
CNRT
NON-FINAL ACTION WRITTEN
03/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/08/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/25/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/25/2020
CNSL
SUSPENSION LETTER WRITTEN
11/25/2020
DOCK
ASSIGNED TO EXAMINER
11/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/30/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/04/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/04/2020
CNSI
SUSPENSION INQUIRY WRITTEN
09/04/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/19/2020
ALIE
ASSIGNED TO LIE
08/14/2020
ALIE
ASSIGNED TO LIE
07/16/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/12/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/12/2019
CNSL
SUSPENSION LETTER WRITTEN
12/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/19/2019
GNRT
NON-FINAL ACTION E-MAILED
07/19/2019
CNRT
NON-FINAL ACTION WRITTEN
07/19/2019
DOCK
ASSIGNED TO EXAMINER
07/15/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2019
NWAP
NEW APPLICATION ENTERED
06/11/2019
Continuous trademark protection
Get notified about every new filing that threatens SKIN GENES RX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.